Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-PLEX for Prevention of Post Abdominal Surgery Incisional Infection
2023-509698-21-00Phase 3Completed
- Sponsor
- PolyPid Ltd.
- Start
- Feb 2024
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 13
01
Overview
Phase 3, randomised, double-blind trial in surgical site infection (SSI) comparing D-PLEX + standard of care with Standard of care control (2 arms). Started Feb 2024; status: completed.
02
Drugs
D-PLEX100
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on 2023-509698-21-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-509698-21-00.